Marco Londei, Chief Medical Officer at ANAPTYSBIO INC (ANAB), sold 160,650 shares at $69.29 ($2.7M) on 2019-01-15, disclosed to the SEC on 2019-01-16.
Open-market sale of $2.7M ANAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 122,500 | $0 | 0.0% |
| 2 | $69.29 | 4,181 | $290K | 10.9% |
| 3 | $69.29 | 4,181 | $290K | 10.9% |
| 4 | $70.04 | 14,894 | $1.0M | 39.1% |
| 5 | $70.04 | 14,894 | $1.0M | 39.1% |
| Total | $16.59 avg | 160,650 |
| $2.7M |
| 100% |
| Filing → |